Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial.
- DOI
- 10.1016/j.ctro.2022.08.013
- Published
- 2022 Nov
- Container
- Clinical and translational radiation oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctro.2022.08.013,
title = {Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial.},
author = {Choi JI and Prabhu K and Hartsell WF and DeWees T and Sinesi C and Vargas C and Benda RK and Cahlon O and Chang AL},
year = {2022},
journal = {Clinical and translational radiation oncology},
doi = {10.1016/j.ctro.2022.08.013},
url = {https://doi.org/10.1016/j.ctro.2022.08.013}
}RIS
TY - JOUR TI - Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial. AU - Choi JI AU - Prabhu K AU - Hartsell WF AU - DeWees T AU - Sinesi C AU - Vargas C AU - Benda RK AU - Cahlon O AU - Chang AL PY - 2022 JO - Clinical and translational radiation oncology DO - 10.1016/j.ctro.2022.08.013 UR - https://doi.org/10.1016/j.ctro.2022.08.013 ER -
APA
JI, C., K, P., WF, H., T, D., C, S., C, V., RK, B., O, C., & AL, C. (2022). Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial.. Clinical and translational radiation oncology. https://doi.org/10.1016/j.ctro.2022.08.013
Source records
- pubmed · retrieved 2026-09-25T09:27:21.317Z